Drug Type Small molecule drug |
Synonyms Ferric sodium gluconate complex, Sodium ferric gluconate complex (USAN), Ferrlecit |
Target- |
Action modulators |
Mechanism Fe modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (18 Feb 1999), |
Regulation- |
Molecular FormulaC6H12FeNaO7 |
InChIKeyBJXSOORTIIARIM-ZBHRUSISSA-N |
CAS Registry34089-81-1 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D05859 | Sodium Ferric Gluconate Complex |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Anemia, Iron-Deficiency | United States | 18 Feb 1999 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Kidney Failure, Chronic | Phase 1 | United States | 01 Sep 2007 | |
| Kidney Failure, Chronic | Phase 1 | Puerto Rico | 01 Sep 2007 | |
| Proteinuria | Phase 1 | United States | 01 Sep 2007 | |
| Proteinuria | Phase 1 | Puerto Rico | 01 Sep 2007 |
Phase 4 | 89 | ejsynuhvuw(piaitqgsaq) = mtjsukyupn exulzhmvuy (fewmmnbmtp, 0.94) View more | - | 29 Mar 2012 | |||
(Oral Iron) | ejsynuhvuw(piaitqgsaq) = emktsgjrhc exulzhmvuy (fewmmnbmtp, 1.11) View more | ||||||
Phase 3 | 502 | DA (DA + IV Iron) | zcszankhho = ubmgsepbcw ddysghnmrb (iaxciamyjw, nvwwoyasdw - cbxvdpclxp) View more | - | 18 Apr 2011 | ||
DA (DA + Oral Iron) | zcszankhho = trbdfrqsmd ddysghnmrb (iaxciamyjw, avzoasruzm - roiypgjwvz) View more | ||||||
Phase 2/3 | 146 | (Sodium Ferric Gluconate Complex 125 mg) | mnrpcjgiiw(cwztampcqb) = ymizdmityv oiagiuuvvq (pheerhmoui, 1.09) View more | - | 28 Sep 2009 | ||
(Sodium Ferric Gluconate Complex 250 mg) | mnrpcjgiiw(cwztampcqb) = aagkvwnnvc oiagiuuvvq (pheerhmoui, 1.35) View more | ||||||
Phase 4 | Maintenance | 23 | wjhutvhebe(rzqzczcvbf) = pcexagblxj lsbxwweaac (pucvxbnxpm ) | - | 01 Apr 2006 |





